During the past decade, Affiliated Hospital of Jiangsu University conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 14 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated Hospital of Jiangsu University" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Takeda" with 3 trials sponsored, "Zensun Sci. & Tech. Co., Ltd." with 3 trials sponsored and "BeiGene" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Jiangsu University" #1 collaborator was "LanZhou University" with 5 trials as a collaborator, "The Sixth People's Hospital of Shenyang" with 4 trials as a collaborator, "Tianjin Second People's Hospital" with 4 trials as a collaborator, "Xingtai People's Hospital" with 4 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Jiangsu University" are "Type 2 Diabetes" (4 trials), "Chronic Heart Failure" (3 trials), "Alzheimer Disease" (2 trials), "Atopic Dermatitis" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Affiliated Hospital of Jiangsu University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Jiangsu University" are "Drug" (47 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "placebo" (4 trials), "rhNRG-1" (3 trials), "Bismuth-Containing Quadruple Therapy" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Jiangsu University" are 56 trials for "All" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Jiangsu University". 2 are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Affiliated Hospital of Jiangsu University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Jiangsu University, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".